These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29745120)

  • 1. Hemolytic uremic syndrome with multiple organ involvement secondary to complement factor H p.Arg1215X mutation.
    Yeşilbaş O; Şevketoğlu E; Petmezci MT; Kıhtır HS; Benzer M; Berdeli A
    Turk J Pediatr; 2017; 59(5):576-580. PubMed ID: 29745120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M; Basturk T; Sahutoglu T; Sakaci T; Koc Y; Ahbap E; Akgol C; Kara E; Brocklebank V; Goodship TH; Kavanagh D; Unsal A
    J Med Case Rep; 2015 Apr; 9():92. PubMed ID: 25925370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant onset severe complement-mediated hemolytic uremic syndrome complicated by secondary sclerosing cholangitis.
    Yesilbas O; Sevketoglu E; Petmezci MT; Kihtir HS; Benzer M; Arikan C; Berdeli A; Baloglu H; Baskan O
    J Clin Apher; 2018 Oct; 33(5):619-623. PubMed ID: 30168181
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab.
    Nakamura H; Anayama M; Makino M; Makino Y; Tamura K; Nagasawa M
    Nephron; 2018; 138(4):324-327. PubMed ID: 29241200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N; Ayer M; Ergen A; Ozturk S
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome.
    Mussoni MP; Veneziano FA; Boetti L; Tassi C; Calisesi C; Nucci S; Rigotti A; Panzini I; Ardissino G
    Transfus Apher Sci; 2014 Oct; 51(2):134-6. PubMed ID: 25294113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Brocklebank V; Johnson S; Sheerin TP; Marks SD; Gilbert RD; Tyerman K; Kinoshita M; Awan A; Kaur A; Webb N; Hegde S; Finlay E; Fitzpatrick M; Walsh PR; Wong EKS; Booth C; Kerecuk L; Salama AD; Almond M; Inward C; Goodship TH; Sheerin NS; Marchbank KJ; Kavanagh D
    Kidney Int; 2017 Nov; 92(5):1261-1271. PubMed ID: 28750931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
    J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
    Wei X; Li J; Zhan X; Tu L; Huang H; Wang Y
    J Med Case Rep; 2022 Mar; 16(1):101. PubMed ID: 35241161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic Microangiopathy with Complement Factor H Gene Mutations Unassociated with Atypical Hemolytic Uremic Syndrome.
    Oymak Y; Karapınar TH; Ay Y; Özcan E; Müminoğlu N; Aydın Köker S; Töret E; Berdeli A; Serdaroğlu E; Vergin C
    Turk J Haematol; 2015 Sep; 32(3):275-6. PubMed ID: 26376595
    [No Abstract]   [Full Text] [Related]  

  • 14. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome.
    Ipe TS; Lim J; Reyes MA; Ero M; Leveque C; Lewis B; Kain J
    J Clin Apher; 2017 Dec; 32(6):584-588. PubMed ID: 28455885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
    Ranch D; Crowther B; Arar M; Assanasen C
    Pediatr Transplant; 2014 Sep; 18(6):E185-9. PubMed ID: 24931815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A; Arjona E; Portoles J; Lopez-Sanchez P; Rabasco C; Espinosa M; Cavero T; Blasco M; Cao M; Manrique J; Cabello-Chavez V; Suñer M; Heras M; Fulladosa X; Belmar L; Sempere A; Peralta C; Castillo L; Arnau A; Praga M; Rodriguez de Cordoba S
    Kidney Int; 2018 Feb; 93(2):450-459. PubMed ID: 28911789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab.
    Yamaguchi M; Hori M; Hiroshi N; Maruyama S
    Thromb Res; 2017 Mar; 151():79-81. PubMed ID: 28167400
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.
    Madden I; Roumenina LT; Langlois-Meurinne H; Guichoux J; Llanas B; Frémeaux-Bacchi V; Harambat J; Godron-Dubrasquet A
    Pediatr Nephrol; 2019 Mar; 34(3):533-537. PubMed ID: 30560448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.
    Tschumi S; Gugger M; Bucher BS; Riedl M; Simonetti GD
    Pediatr Nephrol; 2011 Nov; 26(11):2085-8. PubMed ID: 21877169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.